Viridian Therapeutics Inc Sustainability Reports
Viridian Therapeutics Inc. specializes in the development of novel therapies for the treatment of autoimmune diseases and severe inflammatory conditions.
Sector: Health Care
Country: United States
Exchange: Nasdaq Stock Market
ISIN: US92790C1045
5 reports from 2020 to 2024
Company Profile
Viridian Therapeutics Inc
Viridian Therapeutics Inc. specializes in the development of novel therapies for the treatment of autoimmune diseases and severe inflammatory conditions.
Reports